Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Newsom-Davis

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Lung Cancer Management|January 16, 2019
The route to diagnosis: emergency presentation of lung cancerThomas Newsom-Davis
Clinical Medicine (London, England)|January 25, 2023
Cancer immunotherapy and the management of side effectsPreethika Mahalingam, Thomas Newsom-Davis
F1000 Medicine Reports|February 2, 2011
HIV-associated anal cancerThomas Newsom-Davis, Mark Bower
Apoptosis : an International Journal on Programmed Cell Death|February 6, 2009
Is TRAIL the holy grail of cancer therapy?Thomas Newsom-Davis, Silvia Prieske, Henning Walczak
Postgraduate Medical Journal|October 17, 2013
Novel cancer therapies: treatments driven by tumour biologyRamya Ramaswami, Victoria Harding, Thomas Newsom-Davis
Expert Opinion on Biological Therapy|August 4, 2009
Immunotherapy for HIV-associated non-Hodgkin's lymphomaThomas Newsom-Davis, Eliyaz Ahamed, Mark Bower
Journal of Leukocyte Biology|October 14, 2016
Synovial IL-21/TNF-producing CD4<sup>+</sup> T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytesMaria C Lebre, Pedro L Vieira, Man Wai Tang, et al.
BMC Cancer|June 23, 2009
Case report: malignant teratoma of the uterine corpusThomas Newsom-Davis, Daniel Poulter, Rebecca Gray, et al.
Frontiers in Oncology|February 11, 2026
TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naïve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterationsThomas Newsom-Davis, Barbara Melosky, Rebecca S Heist, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective studyToby Talbot, Adam Dangoor, Riyaz Shah, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Lung Cancer Management|January 16, 2019
The route to diagnosis: emergency presentation of lung cancerThomas Newsom-Davis
Clinical Medicine (London, England)|January 25, 2023
Cancer immunotherapy and the management of side effectsPreethika Mahalingam, Thomas Newsom-Davis
F1000 Medicine Reports|February 2, 2011
HIV-associated anal cancerThomas Newsom-Davis, Mark Bower
Apoptosis : an International Journal on Programmed Cell Death|February 6, 2009
Is TRAIL the holy grail of cancer therapy?Thomas Newsom-Davis, Silvia Prieske, Henning Walczak
Postgraduate Medical Journal|October 17, 2013
Novel cancer therapies: treatments driven by tumour biologyRamya Ramaswami, Victoria Harding, Thomas Newsom-Davis
Expert Opinion on Biological Therapy|August 4, 2009
Immunotherapy for HIV-associated non-Hodgkin's lymphomaThomas Newsom-Davis, Eliyaz Ahamed, Mark Bower
Journal of Leukocyte Biology|October 14, 2016
Synovial IL-21/TNF-producing CD4<sup>+</sup> T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytesMaria C Lebre, Pedro L Vieira, Man Wai Tang, et al.
BMC Cancer|June 23, 2009
Case report: malignant teratoma of the uterine corpusThomas Newsom-Davis, Daniel Poulter, Rebecca Gray, et al.
Frontiers in Oncology|February 11, 2026
TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naïve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterationsThomas Newsom-Davis, Barbara Melosky, Rebecca S Heist, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective studyToby Talbot, Adam Dangoor, Riyaz Shah, et al.
Pageof 4